Figure 4

Three-dimensional diagram of binding sites between active compounds and key targets. (A) Diagram of binding sites between coumaroyltyramine and PI3Kα. (B) Diagram of binding sites between luteolin and AKT1. (C) Diagram of binding sites between cavidine and ERK2. (D) Diagram of binding sites between melianone and STAT3.